Veeva Systems Inc. $VEEV Shares Purchased by Bessemer Group Inc.

Bessemer Group Inc. lifted its holdings in Veeva Systems Inc. (NYSE:VEEV) by 32.9% in the second quarter, Holdings Channel reports. The firm owned 3,162 shares of the technology company’s stock after buying an additional 783 shares during the period. Bessemer Group Inc.’s holdings in Veeva Systems were worth $911,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Vanguard Group Inc. boosted its position in shares of Veeva Systems by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 14,760,566 shares of the technology company’s stock worth $3,418,990,000 after purchasing an additional 315,421 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Veeva Systems by 10.7% in the 1st quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company’s stock worth $1,273,884,000 after purchasing an additional 532,269 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its position in shares of Veeva Systems by 0.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,203,867 shares of the technology company’s stock worth $1,205,372,000 after purchasing an additional 34,169 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Veeva Systems by 20.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock worth $924,754,000 after purchasing an additional 689,700 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Veeva Systems by 7.5% in the 1st quarter. JPMorgan Chase & Co. now owns 3,230,758 shares of the technology company’s stock worth $748,341,000 after purchasing an additional 225,125 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Stock Performance

NYSE VEEV opened at $291.20 on Friday. The stock has a 50-day simple moving average of $285.22 and a two-hundred day simple moving average of $272.19. The firm has a market capitalization of $47.73 billion, a P/E ratio of 59.80, a PEG ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). The company had revenue of $789.08 million for the quarter, compared to analysts’ expectations of $768.49 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The business’s quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Insider Activity at Veeva Systems

In related news, insider Eleni Nitsa Zuppas sold 6,000 shares of Veeva Systems stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the transaction, the insider owned 25,325 shares in the company, valued at $7,765,151.50. The trade was a 19.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jonathan Faddis sold 14,595 shares of Veeva Systems stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the completion of the transaction, the senior vice president owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This represents a 62.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 in the last 90 days. Corporate insiders own 10.30% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on VEEV. KeyCorp raised their price objective on Veeva Systems from $285.00 to $325.00 and gave the stock an “overweight” rating in a research report on Monday, July 14th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Veeva Systems in a research report on Wednesday, October 8th. JPMorgan Chase & Co. raised Veeva Systems from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $290.00 to $330.00 in a research report on Monday, September 8th. Barclays lifted their price target on Veeva Systems from $300.00 to $325.00 and gave the stock an “overweight” rating in a research report on Thursday, August 28th. Finally, Truist Financial lifted their price target on Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a research report on Thursday, August 28th. Seventeen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $307.58.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.